The Side Effects of Quetiapine in Elderly
DOI:
https://doi.org/10.55892/jrg.v7i15.1615Keywords:
Quetiapine, Antipsychotics, Elderly, Risk Factors, Side effectsAbstract
The article addresses the side effects of quetiapine in elderly patients, considering the vulnerability of this population to adverse reactions associated with the use of antipsychotics. In order to identify the main side effects of quetiapine and discuss strategies to mitigate them, a descriptive and qualitative bibliographic review of publications on the subject from the last five years was carried out. The research showed that although quetiapine is effective in treating psychotic and behavioral symptoms in the elderly, it has significant side effects, such as excessive sedation, which increases the risk of falls and fractures, weight gain, metabolic changes and orthostatic hypotension, as well as cognitive impairment. Drug interaction was another risk factor identified, especially considering the prevalence of polypharmacy among the elderly. It was concluded that the use of quetiapine in this age group requires close monitoring and an individualized therapeutic approach in order to minimize risks and optimize patients' quality of life. Careful dose adjustment and periodic assessment of health parameters are also recommended.
Downloads
References
AKINOLA, Pelumi Samuel; TARDIF, Isabelle; LECLERC, Jacinthe. Antipsychotic-induced metabolic syndrome: a review. Metabolic Syndrome and Related Disorders, v. 21, n. 6, p. 294-305, 2023.
AMERICAN GERIATRICS SOCIETY. American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Journal of the American Geriatrics Society, 67(4), 674-694, 2019.
ARAÚJO, Mayara Priscilla Dantas et al. Fatores associados a quedas em idosos hospitalizados: revisão integrativa. Research, Society and Development, v. 11, n. 9, p. e20711931719-e20711931719, 2022.
BEZERRA, Sandro Ritz Alves; TREVISAN, Danilo Donizetti; SECOLI, Silvia Regina. Determinação do risco potencial de interações medicamentosas prolongadoras do intervalo QT em idosos internados em unidade de terapia intensiva. Revista Colombiana de Ciencias Químico-Farmacéuticas, v. 51, n. 2, p. 881-898, 2022.
BHANU, Cini et al. Drug-induced orthostatic hypotension: A systematic review and meta-analysis of randomised controlled trials. PLoS Medicine, v. 18, n. 11, p. e1003821, 2021.
CAIXETA, Leonardo et al. A quetiapina: 3 medicamentos em uma única molécula: uma breve revisão e atualização. Debates em Psiquiatria, v. 13, p. 1-20, 2023.
CARAMELLI, Paulo et al. Tratamento da demência: recomendações do Departamento Científico de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia. Dementia & Neuropsychologia, v. 16, n. 3 suppl 1, p. 88-100, 2022.
DA SILVA, Amanda Pestana et al. Comparison of medication-related fall risk in hospitalized adults and older people: systematic review and probable meta-analysis protocol. Revista Kairós Gerontologia, 2021.
DE BARCELLOS, Maria Aparecida Gonçalves; FRANCO, Camila. Treatment of depression in elderlies with Vortioxetin: a review based on clinical studies. Disciplinarum Scientia| Saúde, v. 23, n. 3, p. 35-54, 2022.
DE MEIRA, Maria Eduarda Antunes et al. Antipsychotic-induced movement disorders: integrative review. HSJ, v. 12, n. 3, p. 44-52, 2022.
DOS SANTOS, Leandra de Cássia Ribeiro et al. Transtorno Bipolar: uma análise das principais terapias empregadas. Brazilian Journal of Implantology and Health Sciences, v. 6, n. 6, p. 1713-1724, 2024.
FULONE, Izabela; SILVA, Marcus Tolentino; LOPES, Luciane Cruz. Use of atypical antipsychotics in the treatment of schizophrenia in the Brazilian National Health System: a cohort study, 2008-2017. Epidemiologia e Serviços de Saúde, v. 32, n. 1, p. e2022556, 2023.
LEITE, Verônica Abreu et al. Prevalence of potential drug interactions of clinical importance in primary health care and its associated factors. Brazilian Journal of Health Review, v. 4, n. 2, p. 6952-6970, 2021.
MENDONÇA, Dayanne Christine Borges et al. Exercício físico é efetivo para sintomas neuropsiquiátricos na doença de Alzheimer: uma revisão sistemática. Arquivos de Neuro-Psiquiatria, v. 79, p. 447-456, 2021.
MICHALCOVA, Jana et al. Inclusion of medication-related fall risk in fall risk assessment tool in geriatric care units. BMC geriatrics, v. 20, p. 1-11, 2020.
MIRANDA, Alexandre; VARGAS, Diva Bernardes. The use of Beers Criteria for safe medication prescription to older adults: drug prescription in the older adults. Peer Review, v. 5, n. 20, p. 482-495, 2023.
MOREIRA, Francisca Sueli Monte et al. Uso de medicamentos potencialmente inapropriados em idosos institucionalizados: prevalência e fatores associados. Ciência & Saúde Coletiva, v. 25, n. 6, p. 2073-2082, 2020.
PALMEIRAS, G. et al. Incidência do uso de benzodiazepínicos em idosos e os riscos associados. Journal of the Health Sciences Institute, v. 40, n. 1, p. 59-66, 2022.
PSCHEIDT, Sabrina Leal et al. Doenças cardiovasculares e uso de antipsicóticos na esquizofrenia: uma revisão. Jornal Brasileiro de Psiquiatria, v. 71, n. 3, p. 253-272, 2022.
RUBINO, A; SANON, M.; GANZ, M. L.; SIMPSON, A.; FENTON, M. C.; VERMA, S.; HARTRY, A.; BAKER, R. A.; DUFFY, R. A.; GWIN, K.; FILLIT, H. Association of the US Food and Drug Administration Antipsychotic Drug Boxed Warning With Medication Use and Health Outcomes in Elderly Patients With Dementia. JAMA Netw Open. 2020.
SEPÚLVEDA-LIZCANO, Lizeth et al. Metabolic adverse effects of psychotropic drug therapy: a systematic review. European Journal of Investigation in Health, Psychology and Education, v. 13, n. 8, p. 1505-1520, 2023.
STOGIOS, Nicolette et al. Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis. Neuropsychopharmacology, v. 47, n. 3, p. 664-672, 2022.
VIEIRA OLIVEIRA, Jéssica Maria et al. Patients diagnosed with mood disorders treated with eletroconvulsive therapy and family perception. SMAD Revista Electronica Salud Mental, Alcohol y Drogas, v. 19, 2023.
